Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · April 01, 2022

Cost Effectiveness of MMS vs WLE in Treating Dermatofibrosarcoma Protuberans

Journal of the American Academy of Dermatology


Additional Info

Journal of the American Academy of Dermatology
Cost effectiveness of dermatofibrosarcoma protuberans treated with Mohs micrographic surgery compared with wide local excision
J Am Acad Dermatol 2022 Feb 22;[EPub Ahead of Print], J Udkoff, E Russell, BT Beal, AM Holzer, DG Brodland, T Knackstedt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading